Vindesine and mitomycin C in metastatic breast cancer. A Southeastern Cancer Study Group Trial

Oncology
A P LyssM Raney

Abstract

64 eligible women with previously treated metastatic breast cancer received mitomycin C plus vindesine chemotherapy. Dosage was based on investigators' estimate of patients' bone marrow reserve. There were 19 evaluable patients in the good marrow reserve category, with two complete and three partial responses (26%). In the poor marrow reserve category there were 29 evaluable patients with four partial responses (14%). The 26% response rate in patients with good marrow reserve is consistent with results obtained with this and similar combinations by other investigators.

Citations

Jan 1, 1993·Breast Cancer Research and Treatment·W ScheithauerD Depisch
Oct 1, 1991·Pharmacology & Therapeutics·E K Rowinsky, R C Donehower
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P S HupperetsG H Blijham
Mar 10, 2001·Cancer Treatment Reviews·W T Bradner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.